
Axcan Pharma Inc. — Investor Relations & Filings
Axcan Pharma Inc. was a specialty pharmaceutical company focused on the development and commercialization of prescription products for diseases and disorders involving the digestive system. The company specialized in providing effective therapies for a range of gastrointestinal conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and cholestatic diseases. Axcan marketed a broad line of products, such as pancrelipase capsules, aimed at improving the quality of care for patients suffering from chronic GI ailments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2008-02-26 | English | |
| Other securityholders documents - English.PDF | 2008-01-14 | English | |
| Material change report - French.PDF | 2007-12-04 | English | |
| Other.pdf | 2007-10-10 | English | |
| Material change report - English.pdf | 2007-08-07 | English | |
| Other.pdf | 2007-07-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2008
2 filings
| |||||
| 47821459 | Material change report - English.pdf | 2008-02-26 | English | ||
| 47821461 | Other securityholders documents - English.PDF | 2008-01-14 | English | ||
|
2007
7 filings
| |||||
| 47821463 | Material change report - French.PDF | 2007-12-04 | English | ||
| 47821465 | Other.pdf | 2007-10-10 | English | ||
| 47821467 | Material change report - English.pdf | 2007-08-07 | English | ||
| 47821469 | Other.pdf | 2007-07-04 | English | ||
| 47821471 | Other.pdf | 2007-06-21 | English | ||
| 47821473 | Material change report - English.pdf | 2007-06-14 | English | ||
| 47821476 | Other.pdf | 2007-05-14 | English | ||
|
2006
6 filings
| |||||
| 47821480 | Material change report - English.pdf | 2006-12-19 | English | ||
| 47821482 | Material change report - English.pdf | 2006-12-11 | English | ||
| 47821484 | Material change report - English.pdf | 2006-09-25 | English | ||
| 47821486 | Material change report - English.pdf | 2006-05-11 | English | ||
| 47821651 | Material change report - English.pdf | 2006-05-08 | English | ||
| 47821653 | Material change report - English.pdf | 2006-02-23 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
Axcan Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/43169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=43169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=43169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=43169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 43169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axcan Pharma Inc. (id: 43169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.